raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79315

D-2-hydroxyglutaric aciduria

Synonyms: D-2-HGA · D-2-hydroxyglutaric acidemia

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Childhood, Infancy, Neonatal
Status
active

D-2-hydroxyglutaric aciduria (D-2-HGA) is a rare clinically variable neurological form of 2-hydroxyglutaric aciduria characterized biochemically by elevated D-2-hydroxyglutaric acid (D-2-HG) in the urine, plasma and cerebrospinal fluid.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enD-2-hydroxyglutaric aciduriaD-2-HGA · D-2-hydroxyglutaric acidemia
frAcidurie D-2-hydroxyglutariqueAcidémie D-2-hydroxyglutarique · D-2-HGA
deD-2-Hydroxy-GlutarazidurieD-2-Hydroxyglutaryl-Azidämie · D-2-HGA
esAciduria D-2-hidroxiglutáricaAcidemia D-2-hidroxiglutárica · D-2-HGA
itAciduria D-2-idrossiglutaricaAcidemia D-2-idrossiglutarica · D-2-HGA
nlD-2-hydroxyglutaaracidurieD-2-HGA · D-2-hydroxyglutaaracidemie
ptAcidúria D-2-hidroxiglutárica
plD-2-acyduria hydroksyglutarowaD-2-HGA · D-2-kwasica hydroksyglutarowa
csD-2-Hydroxyglutarová acidurieD-2-HGA · D-2-Hydroxyglutarová acidémie
ukD-2-гідроксиглутарова ацидуріяD-2-HGA · D-2-гідроксиглутарова ацидемія
zhD-2-羟基戊二酸尿症D-2-羟基戊二酸血症
trD-2-hidroksiglutarik asidüriD-2-HGA · D-2-hidroksiglutarik asidemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM600721Evalidated
OMIM613657BTNTvalidated
ICD-10E72.8NTBTattributedvalidated
ICD-115C50.E1NTBTindexvalidated
MONDO0010924Evalidated
UMLSC1833429Evalidated
GARD5661Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
IDH2Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:5383ENSG0000018205414765015q26.1isocitrate dehydrogenase (NADP(+)) 220847235[PMID]
D2HGDHDisease-causing germline mutation(s) inAssessedHGNC:28358ENSG000001809026091862q37.3D-2-hydroxyglutarate dehydrogenase20020533[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families80 casesWorldwideCase(s)Validated[EXPERT]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2025-08-27
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0040146D-2-hydroxyglutaric acidemia
HP:0012321D-2-hydroxyglutaric aciduria
HP:6000246Elevated CSF D-2-hydroxyglutaric acid concentration
HP:0001263Global developmental delay
Frequent (79-30%)
HP:0001252Hypotonia
HP:0001250Seizure
Occasional (29-5%)
HP:0001638Cardiomyopathy
HP:0100704Cerebral visual impairment
HP:0012448Delayed myelination
HP:0000750Delayed speech and language development
HP:0001298Encephalopathy
HP:0010307Stridor
HP:0002119Ventriculomegaly

Run the differential on the 4 obligate / very frequent terms

Annotation source: 35359529[PMID]_39839460[PMID]

7

Sources for this card